• Download App

β-thalassemia major are at a high risk of developing Hepatitis B

Produced by Modasta: |
Email this to someoneShare on LinkedInTweet about this on TwitterShare on Google+Share on Facebook

Dr. Seemanthini Desai, the leading microbiologist of Dr. Desai Microlab, Bengaluru talks about the increased risk of hepatitis B infection in young patients who are suffering from beta-thalassemia.

Beta-thalassemia is a group of hereditary disorders where the body fails to manufacture the required amount of haemoglobin resulting in anaemia and other complications. For β-thalassemia major children, the treatment modality includes blood transfusion on a regular basis and management of other issues.

Unfortunately, most of the β-thalassemia major patients in India fail to survive beyond 30 years of age.

Beta thalassemia patients are reported to be at a higher risk of suffering from transfusion-transmitted diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). The main reason is the transfusion of infected blood from a donor.

Blood safety and hepatitis vaccines are important measures that should be followed before transfusing red blood cells in thalassemia patients.


Copyright © 2018 Modasta. All rights reserved

Our Partners